Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-29

FDA Approved: METFORMIN HYDROCHLORIDE EXTENDED RELEASE — Original Application (TIME CAP LABORATORIES, INC)

View source ↗

Summary

The FDA approved Time Cap Laboratories, Inc.'s metformin hydrochloride extended-release tablets under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin hydrochloride extended-release (metformin extended-release)

Snippet

ORIG AP for METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)